phase ii study of panobinostat/gembumel with autosct in high-risk or r/r multiple myeloma
Published 1 year ago • 93 plays • Length 3:32Download video MP4
Download video MP3
Similar videos
-
3:34
maintenance therapy following salvage asct for multiple myeloma
-
4:58
findings of a phase i study of anitocabtagene autoleucel for the treatment of r/r myeloma
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
5:12
phase ib/ii study of ptcy, abatacept & short-course tacrolimus for gvhd prevention following pbsct
-
1:17
phase ii study of tosedostat in mds
-
6:13
phase i study of forimtamig, a gprc5dxcd3 bispecific antibody, in r/r multiple myeloma
-
1:26
insight-mm study update: treatment patterns in first and second-line multiple myeloma
-
58:13
optimising transplant outcome in adults allografted for aml
-
5:00
rouleaux formation | peripheral blood smear examination | hematology | multiple myeloma| esr |
-
14:11
【骨髓移植 q&a】3.完成造血幹細胞移植後的注意事項
-
2:13
new therapies in aml - menin inhibitor revumenib (sndx-5613) | eytan m. stein, md | ash 2022 #aml
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:06
phase ib/ii study of viro-t-cell in patients with r/r cml infection after allosct
-
1:42
optimal sequencing of immunotherapies to improve outcomes for patients with multiple myeloma
-
12:17
updated iv and sc results from a phase i dose escalation study of forimtamig with rrmm patients
-
2:38
optimizing outcomes with pre- and post-transplant interventions
-
2:56
early vs. deferred transplantation in al amyloidosis
-
4:59
frontline treatment of transplant-ineligible mm: a changing landscape
-
1:11
personalized risk assessment for transplantation in primary immunodeficiency disorders
-
15:38
new tools for multiple myeloma treatment monitoring
-
6:06
the optimization of stem cell collection in hsct
-
2:34
considerations for transplant in myelofibrosis